SARCOIDOSIS, PULMONARY
Clinical trials for SARCOIDOSIS, PULMONARY explained in plain language.
Never miss a new study
Get alerted when new SARCOIDOSIS, PULMONARY trials appear
Sign up with your email to follow new studies for SARCOIDOSIS, PULMONARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a malaria drug help sarcoidosis patients ditch steroids?
Disease control Recruiting nowThis study tests if hydroxychloroquine, a drug used for malaria and autoimmune diseases, can help people with sarcoidosis take less steroids. About 140 adults with sarcoidosis affecting areas outside the lungs (like skin, eyes, or bones) will receive either hydroxychloroquine or …
Matched conditions: SARCOIDOSIS, PULMONARY
Phase: PHASE4 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated May 26, 2026 07:43 UTC
-
Can a diabetes drug help lung patients lose weight safely?
Symptom relief Recruiting nowThis small pilot study is testing whether semaglutide, a drug already approved for diabetes and weight loss, is safe and tolerable for people with advanced lung diseases like COPD or pulmonary fibrosis. Eight participants will take the drug for 12 weeks and be monitored for side …
Matched conditions: SARCOIDOSIS, PULMONARY
Phase: PHASE1, PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC
-
New study aims to predict lung outcomes in sarcoidosis patients
Knowledge-focused Recruiting nowThis study is creating tools to predict how sarcoidosis will affect the lungs over time. Researchers will collect clinical data and blood markers from 200 adults with sarcoidosis during routine clinic visits. The goal is to help doctors better forecast lung function changes, impr…
Matched conditions: SARCOIDOSIS, PULMONARY
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 26, 2026 07:27 UTC